Related Experiment Video

Updated: Jul 6, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Role of ornithine decarboxylase in breast cancer

Wensheng Deng1, Xian Jiang, Yu Mei

  • 1Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan 250012, China.

Acta Biochimica Et Biophysica Sinica
|March 12, 2008
PubMed

Insights

Ornithine decarboxylase (ODC) is overexpressed in breast cancer, correlating with tumor stage. Inhibiting ODC suppressed cancer cell proliferation and migration, suggesting it

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Ornithine decarboxylase (ODC) is the rate-limiting enzyme in polyamine biosynthesis, converting ornithine to putrescine.
  • Polyamines play crucial roles in cell growth and proliferation, making ODC a potential target in cancer research.

Purpose of the Study:

  • To investigate the role of Ornithine decarboxylase (ODC) in breast cancer.
  • To evaluate ODC as a potential therapeutic target for breast cancer treatment.

Main Methods:

  • Detection of ODC expression in breast cancer tissues and cell lines.
  • Transfection of breast cancer cells with an adenoviral vector carrying antisense ODC (rAd-ODC/Ex3as).
  • Assessment of cell proliferation, cell cycle, colony formation, and migration.

Main Results:

  • ODC was overexpressed in breast cancer tissues and cell lines, with higher levels correlating with advanced tumor stage.
  • Down-regulation of ODC using rAd-ODC/Ex3as suppressed proliferation, induced G0-G1 cell cycle arrest, and inhibited colony formation and migration.
  • ODC inhibition reduced putrescine levels but did not affect spermidine or spermine concentrations.

Conclusions:

  • ODC overexpression is linked to breast cancer progression.
  • ODC acts as a prognostic factor and a potential therapeutic target for breast cancer.
  • Targeting ODC may offer a novel strategy for breast cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...